A group of European experts was commissioned to establish guidelines on the therapeutic
use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until …

BackgroundMeta-analyses have shown that high-frequency (HF) repetitive transcranial
magnetic stimulation (rTMS) has antidepressant properties when compared with sham …

The understanding and treatment of psychiatric disorders, which are known to be
neurobiologically and clinically heterogeneous, could benefit from the data-driven …

Antidepressants are widely prescribed, but their efficacy relative to placebo is modest, in part
because the clinical diagnosis of major depression encompasses biologically …

Reliable and objective biomarkers promise to improve the assessment and treatment of
chronic pain. Resting-state electroencephalography (EEG) is broadly available, easy to use …

Major depressive disorder (MDD) has high population prevalence and is associated with
substantial impact on quality of life, not least due to an unsatisfactory time span of …

The electroencephalogram (EEG) is considered to be a promising method for studying brain
disorders. Because of its non-invasive nature, subjects take a lower risk compared to some …

Objective: Reducing unsuccessful treatment trials could improve depression treatment.
Quantitative EEG (QEEG) may predict treatment response and is being commercially …

Clinical trials on low-frequency repetitive transcranial magnetic stimulation (LF-rTMS) over
the right dorsolateral prefrontal cortex have yielded conflicting evidence concerning its …

OBJECTIVE: Randomized and sham-controlled trials (RCTs) on repetitive transcranial
magnetic stimulation (rTMS) for treating obsessive–compulsive disorder (OCD) have yielded …